Because GNLY preferentially permeabilizes microbial membranes 14 , we hypothesized that GNLY could deliver Gzms into parasites. We treated extracellular T. cruzi trypomastigotes, T. gondii tachyzoites or L. major promastigotes that were fluorescently labeled with mCherry or the lipophilic fluorescent dye FM4-64 with Alexa Fluor 488-labeled inactive GzmB (GzmB-488), with or without a sublytic concentration of GNLY ( Fig. 1a; Supplementary Figs. 1a and 2a) . By using microscopy, we showed that GzmB entered these parasites only in the presence of GNLY. We confirmed these results by analyzing ≥ 300 parasites for every treatment condition and enumerating the number of parasites showing intracellular GzmB ( Supplementary Fig. 1b and Supplementary Data).
To test the hypothesis that GzmB needs both PFN and GNLY to enter intracellular parasites, we added combinations of PFN, GNLY and inactive GzmB-488 to T. cruzi-infected rhesus kidney epithelial cells (LLC-MK2) and T. gondii-infected human foreskin fibroblasts (HFFs) (Fig. 1b and Supplementary Fig. 1c ) and found that PFN delivered GzmB into mammalian cells but not into the parasites within these cells. GzmB only entered intracellular parasites in the presence of both PFN and GNLY.
To determine whether combinations of cytotoxic granule proteins kill intracellular parasites, we next compared host-cell viability, as assessed by [ 51 Cr]-release assays, with survival of intracellular T. cruzi or T. gondii, as assessed by the presence of motile parasites or by plaque assays, respectively. We treated T. cruzi-infected LLC-MK2 cells and T. gondii-infected HFF cells with combinations of PFN, GNLY and GzmB ( Fig. 1c and Supplementary Fig. 3a ) and found that host-cell killing required PFN and GzmB and that this was not enhanced by adding GNLY. Moreover, parasite viability was significantly reduced, but only when all three effector molecules were added. The parasites were killed within 15-30 min, whereas host-cell killing commenced 45-60 min after treatment. Host-cell death was inhibited by pretreatment with the pan-caspase inhibitor zVAD-fmk (which we also refer to as zVAD) and the serine protease inhibitor 3, 4-dichloroisocoumarin (DCI; which blocks Gzm activity), whereas only DCI pretreatment inhibited parasite death. Thus, host-cell and parasite death were independent, and parasite death required a Gzm, PFN and GNLY.
To confirm the role of PFN and GNLY in killer cell-mediated elimination of intracellular parasites, we assessed the killing of anti-CD3-coated T. cruzi-infected RAW 264.7 cells (a mouse macrophage cell line) by interleukin (IL)-15-cultured splenocytes from T. cruziinfected wild-type (WT), GNLY-transgenic (GNLY +/− ) 11 , PFN-deficient (Prf1 −/− ) and Prf1 −/− GNLY +/− mice ( Fig. 1d and Supplementary  Fig. 3b ). Transgenic GNLY +/− mice were generated using a large Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites bacterial artificial chromosome that contains the 5′ and 3′ regulatory domains of the GNLY gene 11, 15 . As a consequence, these mice express GNLY protein at levels similar to those in humans, but only in NK cells and CTLs. Killing of the infected host cell required PFN, and this was not enhanced by the presence of GNLY; inhibiting Gzms or caspases abrogated host-cell killing (Fig. 1d) . Killing of intracellular T. cruzi was greatly enhanced by GNLY and required PFN. The modestly reduced viability of T. cruzi in host cells that were attacked by GNLY-deficient killer cells was probably because dying cells do not fully support parasite growth. DCI treatment, which did not affect target-cell or killer-cell viability on its own (Supplementary Fig. 3c ), blocked intracellular parasite death by GNLY +/− killer cells, but zVADfmk treatment had no effect. Taken together, these results indicate that Gzms, which are delivered into infected host cells by PFN and then into intracellular parasites by GNLY, kill intracellular parasites in a PFN-, GNLY-and Gzm-dependent, but caspase-independent, manner. Moreover, intracellular parasite killing occurs before, and independently of, host-cell killing, which does not require GNLY.
We next examined the morphology of GNLY-and GzmB-treated T. cruzi and T. gondii cells by using transmission electron microscopy (Fig. 2a,b) . Morphological changes, which were completed within 30-60 min after GNLY and GzmB treatment, were similar in both parasites. We first observed mitochondrial swelling and loss of cristae (within 10 and 15 min, respectively). Within 30 min, chromatin condensation, nuclear fragmentation and membrane blebbing-features of mammalian cell apoptosis-were prominent. Because the GNLY-and Gzm-mediated death of bacteria and the caspase-independent CTL-mediated death of mammalian cells are initiated by superoxide-anion generation 15, 16 , we asked whether treatment with a superoxide scavenger (such as Tiron (4,5-dihydroxybenzene-1, 3-disulfonate)) affects T. gondii and T. cruzi death. Treatment with Tiron, which did not affect GzmB, GNLY or PFN activity ( Supplementary Fig. 3d-f) , abrogated the apoptotic morphological changes, suggesting that parasite death caused by GNLY and GzmB is also mediated by superoxide.
We next measured superoxide-anion generation by using dihydroethidium (DHE) staining, hydrogen peroxide (H 2 O 2 ) production by Amplex Red fluorescence, mitochondrial transmembrane potential (∆ϕ) by DilC 1 (hexamethylindodicarbocyanine iodide) and JC-1 (tetraethylbenzimidazolylcarbocyanine iodide) staining, and phosphatidylserine exposure and outer membrane integrity by annexin V and propidium iodide (PI) staining, respectively, in GNLY-and GzmBtreated T. cruzi trypomastigotes, T. gondii tachyzoites and L. major promastigotes ( Fig. 2c-e; Supplementary Figs. 2b,c and 4a-c) . Without treatment, these obligate parasites survived extracellular conditions for more than the 30-to 60-min incubation times used for these assays, although T. gondii was somewhat more fragile than the other parasites. Addition of GNLY or GzmB on its own had modest effects on production of reactive oxygen species (ROS), annexin V staining or cell membrane integrity. However, addition of GzmB and GNLY together generated superoxide anions within mitochondria (as verified by Mitosox fluorescence) and caused loss of ∆ϕ and of annexin V and PI staining. Superoxide is rapidly converted to peroxide by superoxide dismutases (SODs). We observed that treatment of all three parasites with GNLY and GzmB produced H 2 O 2 and that death required active GzmB ( cruzi trypomastigotes that were transfected with an EV or with plasmids expressing WT or mutant oxidative defense enzymes. In e,g, data are mean ± s.e.m. of three independent experiments. In h, data are mean ± s.e.m. of five mice in one experiment. ***P < 0.001, **P < 0.01; by one-way ANOVA relative to untreated cells (e) or to parasites transfected with EV (g,h).
and 4a,b). GzmA could substitute for GzmB in these in vitro assays, suggesting that multiple Gzms can kill parasites ( Supplementary  Fig. 4c and data not shown). Incubation with the ROS scavengers Tiron, MnTBAP, Trolox (TRX), mannitol, N-acetylcysteine (NAC), dimethylthiourea (DMTU) and desferroxamine mesylate (DFO) inhibited T. cruzi death, indicating the importance of ROS in initiating parasite death (Supplementary Fig. 4d ). ROS generation was the earliest event, occurring within 5-10 min of adding GzmB and GNLY to extracellular parasites (Supplementary Fig. 5 ). It was followed within ~5 min by loss of ∆ϕ. Annexin V and PI staining occurred within 45 min in T. cruzi and L. major. The same order of death-related events occurs during mammalian cell apoptosis. The early detection of superoxide anions coupled with the inhibition of death by a superoxide scavenger (Supplementary Fig. 4c,d) suggests that superoxide has a critical role in parasite killing.
The presence of GzmB and GNLY also activated metacaspases and caspase-like activity, as assessed by the fluorescent indicators Ac-VRPR-AMC and CaspaTag, respectively ( Supplementary Fig. 6a,b) . Treatment with staurosporine, a kinase inhibitor that induces mammalian cell apoptosis, also activated caspase-like activity in all three parasites. Activation of a caspase sensor was unexpected as the parasites are not known to express caspases. However, treatment with the pan-caspase inhibitor zVAD-fmk had no effect on parasite death.
ROS oxidize DNA to form abasic sites, which can be detected by 8-oxoguanine staining. GzmB-and GNLY-treated T. cruzi and L. major both showed increased levels of 8-oxoguanine by flow cytometry and fluorescence microscopy ( Supplementary Fig. 6c,d) . However, we did not detect DNA nicking or fragmentation, characteristic features of mammalian cell apoptosis, by TUNEL assays (data not shown), even when the assays were performed 16-24 h after adding GzmB and GNLY. Thus, treatment with GzmB causes oxidative DNA damage, but not DNA fragmentation, in parasites.
T. cruzi's oxidative defense system uses both evolutionarily conserved enzymes and its own unique enzymes ( Supplementary  Fig. 7 ). To identify potential GzmB substrates, we performed differential proteomics analyses of T. cruzi lysates treated with active or inactive GzmB (F.D. and J.L., unpublished data). Proteins involved in oxidative defense or oxidoreduction reactions were overrepresented among the hits. Nanomolar concentrations of GzmB were incubated for 30 min with nine individual purified, recombinant His-tagged anti-oxidant substrate candidates-the superoxide dismutases SodA and SodB, the ascorbate-dependent, mitochondrial and cytoplasmic tryparedoxin peroxidases (APX, MPX, CPX), tryparedoxin (TryX), trypanothione reductase (TR), glutathione reductase (GR) and protein disulfide isomerase (PDI). All nine were cleaved, as assessed by reduced levels of full-length protein or the appearance of a cleavage npg l e t t e r s 2 1 4 VOLUME 22 | NUMBER 2 | FEBRUARY 2016 nature medicine fragment on immunoblots (Fig. 2f, left) .
T. cruzi has no well-defined electron transport chain (ETC) complex I. To identify potential sources of superoxide anions, we also assessed the cleavage of seven T. cruzi oxidoreductive enzymes that were hits in our proteomics analysis-succinate dehydrogenase (Sdh), the electron transfer flavoproteins EtfA and EtfB, NAD-FAD-dependent dehydrogenase (NFDD), NADP-dependent oxidoreductase (NDH), nitrate reductase (NR) and thioldependent reductase (TDR). Except for TDR, all of the proteins were cleaved (Fig. 2f,  right) . Thus, GzmB both induces generation of superoxide anions and destroys parasite mechanisms to detoxify it. To assess the importance of crippling oxidative defense in parasite killing, we treated T. cruzi epimastigotes overexpressing SodB, APX, MPX, CPX or a glutathione peroxidase (GPX1 or GPX2) [17] [18] [19] [20] with GzmB and GNLY and found that overexpression of any of these enzymes, but not their inactive mutants, significantly rescued T. cruzi from death both in vitro (Fig. 2g) and in vivo (Fig. 2h) . Although many mammals express a GNLY gene, rodents do not. To assess GNLY's role in immune protection, we challenged WT or Prf1 −/− BALB/c mice, which either expressed or did not express GNLY, with a dose of the CL-Brener T. cruzi strain that causes cardiac infection and inflammation, and kills most WT animals. Although WT mice developed progressive parasitemia, and 9 of 12 (75%) mice died between 21 d and 29 d after infection (Fig. 3a,b) , GNLY +/− mice not only had dramatically reduced parasitemia, but also were able to survive infection with the parasite-only 2 of 13 (15%) GNLY +/− mice died. PFN-deficient mice had significantly (P < 0.01) higher levels of parasitemia than WT mice, and all of these mice died within 21 d. We compared cardiac parasite load and inflammation on day 18 and found that the mean cardiac parasite load of WT mice was 70 times higher than that in GNLY +/− mice, which also had less cardiac inflammation and cell necrosis (Fig. 3c,d) . PFN-deficient mice, in the presence or absence of GNLY, had about a logfold more parasites in their hearts and more tissue damage. Three WT and 11 GNLY +/− mice that survived to day 40 had no detectable cardiac infection. Thus, both PFN and GNLY contribute to protection from T. cruzi infection, and PFN is essential for GNLY activity in vivo.
To examine whether enhanced oxidative defenses would increase T. cruzi's resistance to treatment with GzmB and GNLY, we compared parasitemia levels in WT and GNLY +/− BALB/c mice infected with parasites that were transfected with an empty vector (EV) or that overexpressed SodB or catalytically active or inactive MPX or CPX (Fig. 2h) . WT mice infected with EV-containing T. cruzi had ~7-fold higher parasitemia levels than GNLY +/− mice, confirming that GNLY helps control infection. Overexpression of the active, but not the inactive, oxidative defense enzymes significantly increased parasitemia levels (~4-fold) in GNLY +/− mice but did not alter parasitemia levels in WT mice. Reinforcing the parasite oxidative defenses protected T. cruzi from treatment with GNLY and GzmB, but there was no effect in the absence of GNLY, suggesting that proteolytic disruption of the parasite's oxidative defenses by GNLY-mediated delivery of granzymes promotes parasite death.
To determine which lymphocyte subsets contribute to the enhanced resistance of GNLY +/− mice to parasite infection, we infected WT and GNLY +/− mice after treatment with a control antibody or with antibodies to specifically deplete CD8 + or CD4 + T cells or NK cells (Fig. 3e and Supplementary Fig. 8a ). Control antibody-treated GNLY +/− mice had significantly reduced parasitemia levels and npg showed enhanced survival, as compared to WT mice. NK cell depletion had no significant effect on parasitemia levels or survival, suggesting that NK cells do not contribute significantly to protection. CD8 + T cell-depleted mice fared the worst-they all died within 23 d and their parasitemia levels were as high as those in Prf1 −/− mice (Fig. 3a) . The parasitemia levels in CD4 + T cell-depleted mice were intermediate to those of WT and CD8 + T cell-depleted mice, and all of the CD4 + T cell-depleted mice died within a few days of the CD8 + T cell-depleted mice. GNLY did not provide a significant survival benefit in either CD4 + T cell-or CD8 + T cell-depleted mice, suggesting that cooperation between CD4 + and CD8 + T cells is needed for GNLY-mediated protection. Cardiac parasite load and histopathology tracked parasitemia levels and survival (Supplementary Fig. 8b,c) .
In control and NK cell-depleted mice, cardiac infection was reduced by ~60-fold in GNLY +/− mice, as compared to WT mice. NK cell depletion had no significant effect on heart infection. Cardiac infection in CD4 + T cell-or CD8 + T cell-depleted mice resembled that in Prf1 −/− mice, and this was not reduced by GNLY. Thus, although CD8 + T cells mostly mediated the protective effect of GNLY, they required CD4 + T cell help. BALB/c mice are more susceptible to T. cruzi infection than C57BL/6J mice, which develop a stronger IFN-γ response. To verify that the protection afforded by GNLY was not specific to BALB/c mice, we compared T. cruzi infection in WT and GNLY +/− C57BL/6J mice (Fig. 3f,g ). As expected, C57BL/6J mice were more resistant to T. cruzi infection than BALB/c mice. Only one of ten WT mice died and no GNLY +/− mice died. Peak parasitemia levels were tenfold higher in WT mice than in GNLY +/− mice. Whereas all of the GNLY +/− mice cleared the parasitemia within 25 d, all of the WT mice had detectable parasitemia at the time of sacrifice on day 33. Thus, GNLY helps to control T. cruzi infection in both backgrounds, although higher levels of IFN-γ may partially compensate for the absence of GNLY in C57BL/6J mice.
To assess the in vivo significance of GNLY against infection by T. gondii, we challenged WT and GNLY +/− mice, in both the BALB/c and C57BL/6J backgrounds, with the type II (Pru strain) of T. gondii (transfected to express luciferase for live-animal imaging), using a parasite dosage that kills most WT animals. The Pru strain killed all of the WT mice by day 16 after infection, whereas all of the GNLY +/− C57BL/6J mice and four of five BALB/c mice survived and cleared the parasitemia, as measured by in vivo imaging and plaque assays (Fig. 4) . Thus, GNLY strongly contributes to protection against T. gondii infection in both mouse backgrounds.
Here we showed that the cytotoxic granule effectors Gzm, PFN and GNLY work together to kill three protozoan parasites that cause human disease. PFN and GNLY disrupt host cell and parasite membranes, respectively, to deliver the Gzms into intracellular parasites, where they proteolytically act to generate ROS and dismantle parasite oxidative defenses. Scavenging superoxide anions, or overexpressing parasite superoxide dismutase or peroxidases-both in vitro and in vivo-inhibited parasite death, indicating the importance of oxidative damage in parasite killing. Parasite mitochondria generated superoxide anions, a step that was rapidly followed by loss of mitochondrial ∆ϕ and later by the induction of classical features of mammalian cell apoptosis within the parasite. Parasite metacaspase and caspase-like activities were activated but neither was needed for death. Protozoan DNA was oxidized but did not undergo double-stranded breaks. Death of the intracellular parasites occurred independently of, and before, host-cell death, which should limit parasite spreading. A GNLY transgene enabled mice to survive parasite challenges that were lethal to nontransgenic WT mice. Because of the dramatic increase in protection afforded by GNLY, the relevance to humans of previous mouse studies that concluded that IFN-γ secretion, rather than cytotoxicity, is the key protective function of CD8 + T cells in T. cruzi infection needs to be re-evaluated.
On the basis of the broad activity of GNLY seen in cholesterolpoor membranes, killer cell-activated microptosis may be helpful in protection against other protozoan parasites (such as that causing malaria), multicellular parasites (helminths) and fungi. Elucidating the shared and distinct features of microptosis in parasites and other pathogens may identify novel antimicrobial drug targets. In preliminary studies we found that Chagas disease patients but not healthy donors have circulating T. cruzi-specific CD8 + T cells that express GNLY, GzmB and PFN (data not shown), suggesting that this immune response may be important in human disease. However, in patients who are chronically infested with high parasite burdens, develop the severe forms of Chagas disease or are co-infected with HIV, there is a good chance that this protective response is impaired and that antiparasite killer cells may not express GNLY and PFN. Further studies of the roles of GNLY, GzmB and PFN in defense against human parasite infection should prove interesting.
MeTHoDS
Methods and any associated references are available in the online version of the paper. T. gondii was cultured in infected HFF cells (American Type Culture Collection (ATCC)) grown in 1% Dulbecco's modified Eagle's medium (DMEM; GIBCO) at 37 °C and tachyzoites were separated from host cells 2-3 d after infection by differential centrifugation as described 21 . T. cruzi were cultured in LLC-MK2 cells (ATCC) grown in 2% DMEM at 37 °C, and trypomastigotes were collected from the supernatant 5-6 d after infection as described 22 . T. cruzi epimastigotes were cultured in liverinfused tryptose (LIT) medium (BD Biosciences) at 27 °C. L. major promastigotes were grown in M199 medium (Sigma-Aldrich) at 27 °C as described 23 .
PFN, GNLY and Gzms. Native human PFN, GNLY (a mixture of the unprocessed 15-kDa and the processed active 9-kDa isoforms) and GzmB were purified from YT-Indy cells 24 (obtained from Z. Brahmi, Indiana University School of Medicine). Recombinant human GzmA and GzmB and inactive serine-to-alanine (S-A) mutants were produced in 293T cells (ATCC) as previously described 25 . For each batch of purified protein, the sublytic concentration of GNLY or PFN was determined for each parasite or host cell, respectively, as the concentration that led to PI staining of 10-20% of cells after 30-60 min. Because the sublytic concentration varies between batches, it was determined for each enzyme preparation. For PFN, the sublytic concentration ranges from 1-100 nM for 10 4 mammalian cells; for GNLY the range is 10-100 nM for 10 5 parasites. GzmB was fluorescently labeled using the Alexa Fluor 488 (AF488) Microscale Protein Labeling Kit (Invitrogen) following the manufacturer's protocols. Unless otherwise indicated, Gzms were used at a final concentration of 200 nM.
Parasite infection. RAW 264.7 and LLC-MK2 (ATCC) were used as host cells for T. cruzi, and HFF cells (ATCC) were used as host cells for T. gondii. Host cells were cultured in K10 (DMEM supplemented with 10% heat-inactivated pooled FBS (FBS) (Gemini Bioproducts), 100 U/ml penicillin G and 100 µg/ml streptomycin sulfate, 6 mM HEPES, 1.6 mM l-glutamine, 50 µM β-mercaptoethanol (Sigma-Aldrich)). Cells were seeded at 10 4 -10 5 cells/well in 96-well plates for in vitro killing experiments or per slide for microscopy and used at ~50% confluence. HFF cells were infected by incubation at 37 °C for 4 h with T. gondii (multiplicity of infection (MOI) = 1) in DMEM containing 1% FBS. RAW 264.7 and LLC-MK2 cells were incubated at 37 °C overnight with T. cruzi (MOI = 30) in DMEM containing 2% FBS. Infected adherent cells were washed three times with medium to remove extracellular parasites.
Imaging GzmB delivery. For extracellular parasite analyses, T. gondii tachyzoites expressing mCherry, T. cruzi trypomastigotes or L. major promastigotes were treated with 500 nM AF488-labeled inactive GzmB ± sublytic GNLY for 1 h at 37 °C and washed with 10 mM arginine in PBS for 10 min before fixation in 2% formalin in PBS and staining of T. cruzi and L. major cell membranes with FM4-64. For intracellular parasite analyses, HFF cells were infected with mCherry-expressing T. gondii or LLC-MK2 cells with DDAO-se (Invitrogen)-labeled T. cruzi as above. Infected host cells (10 5 per sample) were treated in 200 µl Hank's balanced salt solution (HBSS) for 1 h at 37 °C with 500 nM AF488-labeled inactive GzmB ± sublethal amounts of unlabeled GNLY ± sublytic amounts of unlabeled PFN. The slides were washed with 10 mM arginine in PBS for 10 min, fixed in 2% formalin in PBS, and then stained as above. Slides were mounted with VectaShield with DAPI (Vector Labs) and imaged by confocal microscopy using an inverted, fully motorized Axio Observer spinning disk confocal microscope (Carl Zeiss Microimaging, Inc., Thornwood, NY) equipped with a cooled electron multiplication charge-coupled device (CCD) camera with 512 × 512 resolution (QuantEM, Photometics, Tuscon, AZ) and a CSU-X1 spinning disc (Yokogawa Electric, Tokyo, Japan) with lasers that were excited at 405, 488, 561 and 640 nm (Coherent, Santa Clara, CA) and emission filter ranges of 452/45, 525/50, 607/36 and 680 long-pass, respectively (Semrock, Rochester, NY). Images were analyzed using SlideBook V5.0 (Intelligent Imaging Inc., Denver, CO) software. Three-dimensional (3D) image stacks were obtained along the z axis using the 63× oil immersion objective by acquiring sequential optical planes spaced 0.25 µm apart. Raw images were deconvolved using SlideBook. To quantify GzmB internalization, 300-500 parasites were assessed per treatment condition.
